KaydedilenlerDerginizi ekleyin

Dergiler / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 3

Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure ( Author`s Reply )

İBRAHİM GÜL
Oğuzhan YÜCEL
Abdullah ZARARSIZ
Özlem DEMİRPENÇE
Hasan YÜCEL
Ali ZORLU
MEHMET BİRHAN YILMAZ
Sayfa
228–229
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗

Özet

-

🔖

Bu Makaleye Atıf Yap

GÜL, İ., YÜCEL, O., ZARARSIZ, A., DEMİRPENÇE, Ö., YÜCEL, H., ZORLU, A., YILMAZ, M. B. (2018). Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure ( Author`s Reply ). The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 3, 228–229. https://ajindex.com/articles/365252

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Liu CL, Xue ZQ, Gao SP, Chen C, Chen XH, Pan M, et al. The Relationship between Interleukin-6 Promotor Polymorphisms and Slow Coronary Flow Phenomenon. Clin Lab 2016; 62: 947-53.
  2. Yucel O, Gul I, Zararsiz A, Demirpence O, Yucel H, Cinar Z, et al. Association of soluble ST2 with functional capacity in outpatients with heart failure. Herz 2017 Jun 26. doi: 10.1007/s00059-017-4590-1. [Epub ahead of print] [CrossRef] Mueller T, Jaffe AS. Soluble ST2--analytical considerations. Am J Cardiol 2015; 115(7 Suppl): 8B-21B. [CrossRef] Gül İ, Yücel O, Zararsız A, Demirpençe Ö, Yücel H, Zorlu A, et al. Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure. Anatol J Cardiol 2017; 18: 200-5. [CrossRef]